Clinical trial
Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
NCT00429975 · Hospital Mutua de Terrassa, Other · Terminated
Key facts
| NCT number | NCT00429975 |
|---|---|
| Title | Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia |
| Official title | Comparison Between Ceftriaxone and Levofloxacin on Cytokine Expression Over Time in Severe Pneumococcal Pneumonia |
| Lead sponsor | Hospital Mutua de Terrassa, Other |
| Collaborators | Fondo de Investigacion Sanitaria |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pneumonia, Pneumococcal |
| Intervention type | Drug |
| Interventions | levofloxacin, ceftriaxone |
| Enrollment | 45 |
| Start date | Aug 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Feb 1, 2007 |
| Last update posted | Feb 1, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: